Work

Interim Analysis of a Phase II Study of Denileukin Diftitox (Ontak) for Relapsed/Refractory T-Cell Non-Hodgkin’s Lymphoma.

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v104.11.2641.2641

Authors: Nam H. Dang, Barbara Pro, Fredrick B. Hagemeister, Dan Jones, Barry Samuels, Maria A. Rodriguez, Andre Goy, Jorge E. Romaguera, Pamela L. Walker, Larry Kwak, Luis Fayad

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2562431302

FWCI: 1.365

Cites:

Cited by: 6

Related to: 10